Rankings
▼
Calendar
TARA Q4 2015 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TARA
Protara Therapeutics, Inc.
$216M
Q4 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-15.46
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$670,000
Balance Sheet
Total Assets
$68M
Total Liabilities
$4M
Stockholders' Equity
$63M
Cash & Equivalents
$40M
← FY 2015
All Quarters
Q1 2016 →